Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - Randomized, Controlled, Open-label Intervention, Multi-center Trial (CYCOV-II-study)

NCT04385771 is registered in ClinicalTrials.gov with Dr. Alexander Supady as lead sponsor.

NCT NCT04385771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation - Randomized, Controlled, Open-label Intervention, Multi-center Trial (CYCOV-II-study)
Lead sponsor
Dr. Alexander Supady
Phase
Not applicable
Overall status
Suspended
Start date
September 1, 2020
Completion date
October 31, 2021
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid, cytokine storm, extracorporeal membrane oxygenation, respiratory failure, sars-cov 2